By Susanna Moon
Chicago, Sept. 23 – UBS AG, London Branch priced $4.91 million of trigger phoenix autocallable optimization securities due March 28, 2016 linked to Celgene Corp. shares, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 10% if the stock closes at or above its barrier level, 75% of its initial level, on an observation date for that quarter.
The notes will be called at par if Celgene stock closes at or above its initial level on any quarterly observation date after one year.
If the notes are not called and Celgene stock finishes at or above its 75% barrier level, the payout at maturity will be par.
Otherwise, investors will be exposed to any losses.
UBS Financial Services Inc. and UBS Investment Bank are the underwriters.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger phoenix autocallable optimization securities
|
Underlying stock: | Celgene Corp. (Symbol: CELG)
|
Amount: | $4,909,950
|
Maturity: | March 28, 2016
|
Coupon: | 10% annualized for each quarter that stock closes at or above coupon barrier level on quarterly observation date
|
Price: | Par
|
Payout at maturity: | If stock finishes at or above trigger level, par; otherwise, full exposure to losses
|
Call: | At par if stock closes at or above initial level on any quarterly observation date after one year
|
Initial level: | $93.85
|
Barrier level: | $70.39, 75% of initial level
|
Pricing date: | Sept. 19
|
Settlement date: | Sept. 24
|
Underwriters: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 1.5%
|
Cusip: | 90273L732
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.